90s football pinups now from secret affairs to cancer and drug abuse
The article explores the tumultuous post-career lives of 90s football stars, highlighting scandals, health issues, and personal struggles that have overshadowed their athletic achievements.
A living drug eliminates tumors in mice with pancreatic, ovarian, or kidney cancer
A new living drug, a highly sensitive version of the CAR-T therapy, has successfully eliminated tumors in lab mice suffering from pancreatic, ovarian, and kidney cancers.
Pancreatic cancer, with this drug a decisive turning point approaches: the approval of Aifa
A new drug, Olaparib, is set to be approved for the treatment of metastatic pancreatic cancer, marking a significant advance in the battle against this deadly disease.
Anvisa seizes counterfeit cancer drug, fake batch of Mounjaro, and bans 'hormonal chip' in the country
Brazil's health regulatory agency Anvisa has seized counterfeit batches of several drugs including Mounjaro and prohibited the compounding of hormonal implants.
Possible lung cancer diagnosis wins Lebanese opioid dealer a chance to avoid deportation from Canada
A Lebanese immigrant convicted of drug trafficking has secured a reprieve from deportation due to a potential lung cancer diagnosis.
New Ruling for Drug Company – Found Responsible in Case of Woman Who Died of Cancer
Johnson & Johnson was ordered to pay $250,000 in a case linked to ovarian cancer where it failed to warn consumers of product risks.
Medication in Mice is Not the Same as Medication in Humans: About How the Report of Scientists Finding a Cure for Pancreatic Cancer Inflated
Recent claims of a breakthrough cure for pancreatic cancer by Spanish scientists have led to overwhelming inquiries from patients, but the implications of such a treatment's effectiveness in humans remain uncertain.
Pharmaceutical company Orion achieved strong results
Finnish pharmaceutical company Orion reported a 60% increase in revenue for Q4, significantly driven by the sales of its prostate cancer drug, Nubeqa.
AstraZeneca profit rises as cancer drug sales grow
AstraZeneca reported a 45% increase in net profit for 2025, driven by robust sales of cancer drugs and expansion in the U.S. and China.
Fosun Pharma’s US$1.55 billion Eisai deal signals shift to long-term partnerships
Fosun Pharma has signed a US$1.55 billion licensing deal with Japan's Eisai for a cancer drug, indicating a trend towards long-term partnerships in the global pharmaceutical industry.
Development of an Oral Administration Nanoplatform for Continuous Tumor Destruction and Immune Induction through Joint Research of Kyung Hee University and Mokpo University
Researchers from Kyung Hee University and Mokpo University have collaboratively developed an oral lipid nanoplatform capable of inducing continuous ferroptosis and immune reprogramming in tumors, aimed at enhancing drug delivery and immune response against triple-negative breast cancer.
A drug that destroys cancer cells is coming to Lithuania - doctors are thrilled: "It sounds like science fiction"
Lithuanian health officials are excited about the arrival of a new drug that uses teranostics to improve cancer treatment and increase patient survival rates.
Day of Fight Against Cancer. Scientist: It is worth paying attention to what precedes clinical trials
The article discusses the increasing cancer challenges, focusing on the importance of understanding drug effectiveness before clinical trials, as cancer remains a leading cause of death in Poland.
Who is the blue athlete stopped by doping
The first doping case shakes the Milan-Cortina 2026 Olympics just days before the event begins, involving 24-year-old Rebecca Passler, who tested positive for letrozole, a drug commonly used in post-menopausal women for hormone-dependent breast cancer.
NHS expands access to prostate cancer drug in England to save thousands of lives
The NHS has broadened the availability of the prostate cancer drug Abiraterone to newly diagnosed patients in England, aiming to save thousands of lives by providing treatment earlier in the disease process.
The CNIO closes its cancer drug development and diagnostic units
The National Center for Cancer Research (CNIO) has shut down its cancer diagnosis and drug development units while launching a new action plan focusing on artificial intelligence and computational methodologies.
The CNIO closes its cancer diagnosis and new drug development units
The National Cancer Research Center (CNIO) will close three scientific units, impacting over 20 employees amid an unprecedented crisis.
The concentration of the drug that killed two cancer patients at the Burgos Hospital was six times higher than recommended
Two cancer patients died at Burgos Hospital due to a human error in the preparation of a medication, which was administered at six times the recommended concentration.
I'm dying - and losing friends too soon because we can't get vital drug
Sophie Blake, a terminally ill mother from Brighton with stage four breast cancer, expresses her anguish over losing friends and being denied a vital life-extending drug by the Government.